
[ Thu, Sep 23rd 2021 ]: WOPRAI

[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI

[ Tue, Sep 21st 2021 ]: WOPRAI
Paul Choi Downgraded (VIR) to Hold and Decreased Target to $62 on, Sep 22nd, 2021


🞛 This publication is a summary or evaluation of another publication
Paul Choi of Goldman Sachs, Downgraded "Vir Biotechnology, Inc." (VIR) to Hold and Decreased Target from $64 to $62 on, Sep 22nd, 2021.
Paul has made no other calls on VIR in the last 4 months.
There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, 0 agree with Paul's Rating of Hold.
This is the rating of the analyst that currently disagrees with Paul
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021